In the present study, we demonstrated that either the downregulation of MMP-9 (pM) or overexpression of miR-211 increases chemo- and radio-sensitivity of glioma CSC, suggesting that rescuing miR-211 expression may have a new therapeutic application in the treatment of GBM patients in the future. This evidence concerns the gene MMP9 and glioma.